Efficacy and Safety of Galcanezumab as a Preventive Treatment for Episodic Migraine in South Korean Patients: A Post-Hoc Analysis of a Phase 3 Clinical Trial

CONCLUSIONS: Galcanezumab treatment demonstrated efficacy and a favorable safety and tolerability profile in South Korean patients with EM.PMID:37455511 | DOI:10.3988/jcn.2022.0180

Source: Journal of Clinical Neurology - July 17, 2023 Category: Neurology Authors: Byung-Kun Kim Soo-Jin Cho Jeong Hee Han Grazia Dell'Agnello Tommaso Panni Manho Kim Kyungmi Oh Heui-Soo Moon Min Kyung Chu Source Type: research